Long-term follow-up of cyclophosphamide compared with azathioprine for initial maintenance therapy in ANCA-associated vasculitis.
about
Interventions for renal vasculitis in adultsRecent advances in understanding and treating vasculitisRecent advances in anti-neutrophil cytoplasmic antibody-associated vasculitisTrends in Long-Term Outcomes Among Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Renal DiseaseMaintenance therapy in antineutrophil cytoplasmic antibody-associated vasculitis: who needs what and for how long?Treatment of granulomatosis with polyangiitis (Wegener's).Twenty-five years of European Union collaboration in ANCA-associated vasculitis research.Conventional induction and maintenance treatment of Antineutrophil cytoplasmic antibodies-associated vasculitis - still of value for our patients?Association of Serum Calprotectin (S100A8/A9) Level With Disease Relapse in Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.Vasculitis for the internist: focus on ANCA-associated vasculitis.Clinical Trials in Vasculitis.Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.Long term azathioprine maintenance therapy in ANCA-associated vasculitis: combined results of long-term follow-up data.Cancer in ANCA-Associated Glomerulonephritis: A Registry-Based Cohort Study.Anti-neutrophil cytoplasmic antibody-associated vasculitis: prevalence, treatment, and outcomes.
P2860
Q24187038-34756D00-2DFE-4FA9-A49A-4589CF7B9689Q26747046-B863F445-CB05-4C38-AD0A-D9BA34D9AFB2Q26751357-B70D48ED-DC5E-4660-B7E8-D9AE0789D2A9Q37037298-A6BF49D2-56C7-4D1B-A168-B2BDE4D28CA6Q38327634-BD63A27F-3F35-4CF8-A42B-15E1843093F7Q38341601-82013C86-51F5-4B6B-8E30-9DA0FC79C937Q38389839-D81F287C-231C-48D2-81EF-A7E51FB19CE6Q38543360-C828951F-E251-45E0-AE51-A5A030EE9883Q38840696-44B9929F-F5F1-4D87-9046-83B51D14AD4EQ39379384-40EE4939-DE8C-42E5-B63C-297A6CABD315Q41481664-C4A85376-88D2-4AC6-B980-0CF0D25001BFQ42706595-4071BB19-F347-4BC3-9EE9-1EABF737BABAQ47700123-FAC763DE-65C3-42A4-BB95-B26E9D439809Q48102349-F6F84AF8-9F18-4503-8422-053FC827A4FEQ49691317-C37AAD58-7C5D-47DB-8A49-711DDCF21FC6
P2860
Long-term follow-up of cyclophosphamide compared with azathioprine for initial maintenance therapy in ANCA-associated vasculitis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Long-term follow-up of cycloph ...... in ANCA-associated vasculitis.
@ast
Long-term follow-up of cycloph ...... in ANCA-associated vasculitis.
@en
Long-term follow-up of cycloph ...... in ANCA-associated vasculitis.
@nl
type
label
Long-term follow-up of cycloph ...... in ANCA-associated vasculitis.
@ast
Long-term follow-up of cycloph ...... in ANCA-associated vasculitis.
@en
Long-term follow-up of cycloph ...... in ANCA-associated vasculitis.
@nl
prefLabel
Long-term follow-up of cycloph ...... in ANCA-associated vasculitis.
@ast
Long-term follow-up of cycloph ...... in ANCA-associated vasculitis.
@en
Long-term follow-up of cycloph ...... in ANCA-associated vasculitis.
@nl
P2093
P2860
P356
P1476
Long-term follow-up of cycloph ...... in ANCA-associated vasculitis.
@en
P2093
Annelies Berden
Charles D Pusey
David R W Jayne
European Vasculitis Study Group
Ingeborg Bajema
Kerstin Westman
Michael Walsh
Mikkel Faurschou
Rona Smith
Wladimir Szpirt
P2860
P304
P356
10.2215/CJN.00100114
P577
2014-06-26T00:00:00Z